In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves LAS VEGAS, Oct. 9, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is featured in the October 2019 edition of t

SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ -- AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concept study evaluating the use of the

OSLO, Norway, Oct. 9, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that the Company and its collaborators at Orano Med will present data and analyses from preclinical studies with 212Pb-NNV003, a CD37 targeting alpha-radioimmunotherapy for the treatment of leukaemia and lymphoma at the 2019 Annual Congress of the European Association of Nuc

NORTH CHICAGO, Ill., Oct. 9, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that it will present new results evaluating the safety and efficacy of SKYRIZI™ (risankizumab) at 2.5 years in adult patients with moderate to severe plaque psoriasis, as well as additional data on HUMIRA® (adalimu

OSLO, Norway, Oct. 9, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), announces that clinical data on the company's lead product candidate ONCOS-102, a genetically modified oncolytic adenovirus which has been engineered to selectively infect and replicate in cancer cells, will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting being held

CHAPEL HILL, N.C., Oct. 9, 2019 /PRNewswire/ -- On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless of where they live, should be able to to expect that their hospital stay is safe and that the risk of adverse events such as thrombosis is minimized. Thrombosis is the formation of potentially dea

NASHVILLE, Tenn., Oct. 8, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today issued the following statement on the withdrawal of the director nomination by Land & Buildings in connection with the Company's 2019 Annual Meeting of Stockholders:

DALLAS, Oct. 8, 2019 /PRNewswire/ -- On October 4, 2019, the U.S. Court of Appeals for the Federal Circuit affirmed McKool Smith's inter partes review (IP

PROVO, Utah, Oct. 8, 2019 /PRNewswire/ -- Nu Skin's 35 years of expertise in beauty and wellness is propelled into the future with a strong emphasis in science, technology and sourcing. Through its published research on gene expression science, award-winning beauty device technology and a 6S quality process to ensure the use of safe, efficacious ingredients, Nu Skin has

LAKE FOREST, Calif., Oct. 8, 2019 /PRNewswire/ -- This month, Celebrate A New Life announced the opening of TruVida's residential drug treatment retreat. Celebrate A New Life's Director of Admissions, Robert (Bobby) Nicholl reports that TruVida is preparing additional homes to welcome additional clients looking for a